Auspex Pharma Stockholders Encouraged to Contact Securities Law Firm about Takeover

NEW YORK, March 30, 2015 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating the board of Auspex Pharma (NASDAQ: ASPX) in connection with a buyout for only $101.00 per share. Concerned ASPX investors are encouraged to contact attorney Hamilton Lindley by clicking here.

The investigation focuses upon the shareholder value of the transaction. Under terms of the proposed agreement, Auspex's shareholders would receive only $101.00 per share.  However, at least one analyst has set a target price of $105.00.  The firm's potential shareholder lawsuit will seek to obtain the highest price reasonably available and that all important information about the deal is disclosed.

Dunnam & Dunnam has significant experience representing shareholders in securities lawsuits nationwide. ASPX stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at [email protected] with questions, toll free at (844) 702-2990 or visit http://www.dunnamlaw.com/ASPX.

Find these Waco divorce lawyers on social media on Google+, LinkedIn, Facebook, and Twitter.

SOURCE Dunnam & Dunnam

Related Links

http://www.dunnamlaw.com